
Klea Holding (ALKLH) | Financial Analysis & Statements
Klea Holding Inc. | Small-cap | Healthcare
Klea Holding Inc. | Small-cap | Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2018Income Metrics
EPS (Diluted)
€0.00
Balance Sheet Metrics
Total Assets
37.8M
Total Liabilities
10.0M
Shareholders Equity
27.8M
Debt to Equity
0.36
Cash Flow Metrics
Revenue & Profitability Trend
Klea Holding Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 17.3M | 13.7M | 14.4M | 7.2M | 19.0M |
Cost of Goods Sold | 9.0M | 7.4M | 11.2M | 7.9M | 22.7M |
Gross Profit | 8.3M | 6.3M | 3.2M | -715.0K | -3.8M |
Gross Margin % | 47.8% | 46.0% | 22.2% | -10.0% | -19.8% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | - | - | - |
Other Operating Expenses | - | 23.0K | 801.0K | 832.0K | -786.0K |
Total Operating Expenses | 0 | 23.0K | 801.0K | 832.0K | -786.0K |
Operating Income | 1.9M | 952.0K | -3.9M | -3.7M | -6.6M |
Operating Margin % | 11.3% | 6.9% | -27.1% | -51.3% | -34.8% |
Non-Operating Items | |||||
Interest Income | 275.0K | 112.0K | 4.0K | 12.0K | - |
Interest Expense | 758.0K | 1.2M | 182.0K | 618.0K | 382.0K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 1.5M | 1.5M | -5.1M | -4.2M | -5.2M |
Income Tax | 267.0K | -37.0K | 113.0K | 142.0K | -164.0K |
Effective Tax Rate % | 17.8% | -2.4% | 0.0% | 0.0% | 0.0% |
Net Income | 1.4M | 902.0K | -5.3M | -4.5M | -5.2M |
Net Margin % | 8.1% | 6.6% | -36.5% | -62.1% | -27.1% |
Key Metrics | |||||
EBITDA | 3.8M | 4.2M | -1.2M | -2.9M | -6.7M |
EPS (Basic) | - | €0.00 | €-0.02 | €-0.03 | €-0.20 |
EPS (Diluted) | - | €0.00 | €-0.02 | €-0.03 | €-0.20 |
Basic Shares Outstanding | - | 294356419 | 263850000 | 138087389 | 25382874 |
Diluted Shares Outstanding | - | 294356419 | 263850000 | 138087389 | 25382874 |
Income Statement Trend
Klea Holding Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 3.3M | 3.0M | 2.4M | 6.6M | 779.0K |
Short-term Investments | - | - | - | 7.0K | 31.0K |
Accounts Receivable | 1.7M | 1.2M | 1.8M | 4.6M | 252.0K |
Inventory | 19.0K | 0 | 658.0K | 1.4M | 1.3M |
Other Current Assets | 2.0K | - | 410.0K | 203.0K | 330.0K |
Total Current Assets | 7.1M | 5.3M | 7.0M | 16.0M | 5.1M |
Non-Current Assets | |||||
Property, Plant & Equipment | 8.2M | 7.3M | 13.0M | 8.5M | 1.0M |
Goodwill | 49.7M | 49.5M | 38.3M | 44.1M | 541.0K |
Intangible Assets | 539.0K | 356.0K | 374.0K | 90.0K | 97.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | 1.0K | -1.0K | -101.0K | 1.0K |
Total Non-Current Assets | 30.7M | 31.3M | 29.1M | 28.1M | 832.0K |
Total Assets | 37.8M | 36.6M | 36.1M | 44.1M | 5.9M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 1.6M | 2.1M | 3.0M | 17.3M | 5.2M |
Short-term Debt | 97.0K | 287.0K | 127.0K | 5.0M | 2.0K |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | 310.0K | 13.0M | 69.0K |
Total Current Liabilities | 3.5M | 3.4M | 5.5M | 24.2M | 8.8M |
Non-Current Liabilities | |||||
Long-term Debt | 5.8M | 7.6M | 5.5M | 0 | 13.0K |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | -1.0K | -1.0K | 1.2M | 406.0K |
Total Non-Current Liabilities | 6.5M | 8.5M | 6.3M | 5.8M | 1.5M |
Total Liabilities | 10.0M | 11.8M | 11.8M | 30.0M | 10.3M |
Equity | |||||
Common Stock | 3.1M | 2.9M | 2.9M | 1.4M | 20.3M |
Retained Earnings | 1.4M | 902.0K | -5.3M | -4.5M | -36.7M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 27.8M | 24.7M | 24.3M | 14.1M | -4.4M |
Key Metrics | |||||
Total Debt | 5.9M | 7.9M | 5.6M | 5.0M | 15.0K |
Working Capital | 3.6M | 1.9M | 1.5M | -8.2M | -3.7M |
Balance Sheet Composition
Klea Holding Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 1.2M | 902.0K | -5.3M | -4.5M | -5.2M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 0 | 0 | 0 | 0 | 0 |
Operating Cash Flow | 769.0K | -1.3M | -5.3M | -4.5M | -5.2M |
Investing Activities | |||||
Capital Expenditures | -626.0K | -1.8M | -5.5M | -171.0K | 3.1M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -626.0K | -1.6M | -17.5M | -15.0M | 3.1M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 2.0M | 2.4M | 12.2M | 26.0M | 1.6M |
Debt Repayment | -3.9M | -1.3M | -650.0K | -713.0K | -1.6M |
Financing Cash Flow | -199.0K | 1.0M | 14.8M | 27.2M | 0 |
Free Cash Flow | 166.0K | -1.5M | -7.3M | -6.7M | -11.1M |
Net Change in Cash | -56.0K | -1.8M | -8.0M | 7.7M | -2.1M |
Cash Flow Trend
Klea Holding Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
17.87
Price to Book
2.27
Price to Sales
3.74
Profitability Ratios
Profit Margin
8.14%
Operating Margin
14.55%
Return on Equity
5.35%
Return on Assets
3.27%
Financial Health
Current Ratio
1.41
Debt to Equity
21.13
Beta
-1.12
Per Share Data
EPS (TTM)
€0.00
Book Value per Share
€0.09
Revenue per Share
€0.06
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
alklh | 64.5M | 17.87 | 2.27 | 5.35% | 8.14% | 21.13 |
bioMérieux S.A | 15.0B | 35.00 | 3.57 | 10.68% | 10.86% | 11.65 |
Eurofins Scientific | 12.2B | 30.01 | 3.53 | 8.68% | 6.05% | 88.06 |
Eurofins Cerep SAS | 92.8M | 12.97 | - | 10.49% | 17.67% | 0.46 |
Predilife S.A | 12.3M | - | - | -4,653.75% | 97.76% | -1.16 |
Lumibird S.A | 400.6M | 70.00 | 2.02 | 2.91% | 2.71% | 81.34 |
Financial data is updated regularly. All figures are in the company's reporting currency.